Backwash Ileitis in Ulcerative Colitis

Definition and Epidemiology

Approximately 20 % of patients with extensive or pancolitis develop “backwash ileitis,” a continuous extension of colonic inflammation from the cecum into the terminal ileum; this is the only recognized form of small‑bowel involvement in ulcerative colitis. 1
Ulcerative colitis is defined by diffuse mucosal inflammation that is confined to the colon, distinguishing it from Crohn’s disease, which can affect any gastrointestinal segment. 1

The ileal inflammation in backwash ileitis is typically mild, limited to a few centimeters of the terminal ileum, and lacks discrete ulceration or deep ulcer formation. 2
Histologic examination of ileal biopsies from ulcerative colitis patients with backwash ileitis does not reveal pyloric gland metaplasia, a feature that is common in Crohn’s disease involving the ileum. 3

Backwash ileitis shows a continuous pattern of inflammation extending directly from the cecum, whereas Crohn’s disease exhibits skip lesions and a patchy distribution throughout the small bowel. 2
In Crohn’s ileitis, deeper ulcerations, strictures, and transmural inflammation are typical; these findings are absent in backwash ileitis. 2

When macroscopic terminal‑ileum inflammation is observed in a patient with extensive colitis, clinicians should not automatically label the case as Crohn’s disease; recognition of backwash ileitis as a variant of ulcerative colitis is essential. 2
Assessment should include evaluation for rectal involvement, skip lesions, and discrete ileal ulcers—features that favor Crohn’s disease over backwash ileitis. 2
Routine small‑bowel imaging (CT/MR enterography) or capsule endoscopy is not indicated in ulcerative colitis unless atypical findings raise suspicion for Crohn’s disease. (Guideline recommendation based on the absence of supporting citations; therefore omitted from bullet list.)

Presence of backwash ileitis may be associated with a more refractory disease course and an increased risk of colonic neoplasia in surgical specimens, underscoring the need for vigilant surveillance. (Citation not provided; therefore excluded from bullet list.)

Backwash ileitis occurs in approximately 20% of patients with extensive colitis, representing continuous extension of macroscopic or histological inflammation from the cecum into the terminal ileum 4, 5, 6, 7
The inflammation extends continuously from the cecum without skip lesions, distinguishing it from Crohn's disease 4
Patients with backwash ileitis are prone to a more refractory disease course, including an increased risk of colon neoplasia in proctocolectomy specimens 4, 5, 6

When macroscopic backwash ileitis is identified, additional small bowel imaging should be considered to differentiate UC from Crohn's disease 4, 5, 8
Small bowel radiology (CT/MR enterography) or capsule endoscopy is NOT routinely recommended in UC 4, 5, 8
Evaluate the small bowel when macroscopic and histological rectal sparing or a cecal patch is present in newly diagnosed colitis, or when macroscopic backwash ileitis is identified 4, 5

UC with backwash ileitis shows continuous inflammation extending from the cecum, whereas Crohn's disease demonstrates skip lesions and patchy distribution 4, 9
Rectal sparing is rare in UC (≤3% of cases) but common in Crohn's disease, making this a key distinguishing feature 10, 7
UC inflammation is limited to mucosa/submucosa, while Crohn's disease is transmural 9

In 5-15% of IBD patients, endoscopic and histological assessments cannot distinguish between Crohn's colitis and UC, leading to classification as IBD-unclassified (IBD-U) 10, 7
Capsule endoscopy can establish a definitive diagnosis by demonstrating small bowel lesions compatible with Crohn's disease in 17-70% of patients with IBD-U 11